Nanomedicine-based immunotherapy for central nervous system disorders
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine-based immunotherapy for central nervous system disorders
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-28
DOI
10.1038/s41401-020-0429-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy
- (2020) Yanjie Liu et al. NANO LETTERS
- Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases
- (2019) Asahi Tomitaka et al. DRUG DISCOVERY TODAY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- A walk through tau therapeutic strategies
- (2019) Santosh Jadhav et al. Acta Neuropathologica Communications
- The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma
- (2019) Vivek Bhaskaran et al. Nature Communications
- Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment
- (2019) Chiara Bastiancich et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy
- (2019) Gulsah Erel-Akbaba et al. ACS Nano
- Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody
- (2019) Marie Albert et al. BRAIN
- ROS‐Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy
- (2019) Meng Zheng et al. ADVANCED MATERIALS
- Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo
- (2019) Kristen L. Kozielski et al. BIOMATERIALS
- A tumor‐targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti‐PD‐1 immunotherapy in mouse models of glioblastoma
- (2019) Sang‐Soo Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis
- (2019) Michael X. Henderson et al. NATURE NEUROSCIENCE
- Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy
- (2019) Inglut et al. Journal of Clinical Medicine
- Biodegradable Mesoporous Silica Achieved via Carbon Nanodots-Incorporated Framework Swelling for Debris-Mediated Photothermal Synergistic Immunotherapy
- (2019) Min Qian et al. NANO LETTERS
- Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
- (2019) Anna Galstyan et al. Nature Communications
- An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
- (2019) Ruiyuan Liu et al. Advanced Science
- iRGD Modified Chemo-immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma
- (2018) Jing Kuang et al. ADVANCED FUNCTIONAL MATERIALS
- Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi-Based Immunochemotherapy of Intracranial Glioblastoma Treatment
- (2018) Chenmeng Qiao et al. ADVANCED MATERIALS
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment
- (2018) Thomas A. Burley et al. INTERNATIONAL JOURNAL OF CANCER
- Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
- (2018) Yuan Peng et al. International Journal of Nanomedicine
- Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care
- (2018) Stephanie Behrens et al. INTERNATIONAL PSYCHOGERIATRICS
- Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease
- (2018) Donghoon Kim et al. Nature Nanotechnology
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
- (2018) Stephen J Bagley et al. NEURO-ONCOLOGY
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects
- (2018) Huang-Chiao Huang et al. Small
- Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy
- (2018) Meng Zheng et al. TRENDS IN BIOTECHNOLOGY
- Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling
- (2018) Barbara Oldrini et al. Nature Communications
- Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody
- (2018) Tadanobu Nagaya et al. Oncotarget
- Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy
- (2018) Elif Ozdemir-Kaynak et al. Frontiers in Physiology
- Recent advances in applying nanotechnologies for cancer immunotherapy
- (2018) Reza Mahjub et al. JOURNAL OF CONTROLLED RELEASE
- Immunomodulating Nanomedicine for Cancer Therapy
- (2018) Zhigang Liu et al. NANO LETTERS
- Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
- (2018) Jordi Pujols et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination Glioma Therapy Mediated by a Dual-Targeted Delivery System Constructed Using OMCN-PEG-Pep22/DOX
- (2018) Wenbo Qian et al. Small
- Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine
- (2018) Yan Zou et al. ADVANCED MATERIALS
- Promising vaccines for treating glioblastoma
- (2018) Adam M. Swartz et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes
- (2018) Yanan Shi et al. JOURNAL OF CONTROLLED RELEASE
- New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
- (2018) Guoxin Zhang et al. Frontiers in Aging Neuroscience
- Current trends in mouse models of glioblastoma
- (2017) Masafumi Miyai et al. JOURNAL OF NEURO-ONCOLOGY
- RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
- (2017) Eunice L. Lozada-Delgado et al. LIFE SCIENCES
- Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma
- (2017) Shanshan Wang et al. MOLECULAR THERAPY
- Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma
- (2017) Maria-Carmela Speranza et al. NEURO-ONCOLOGY
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
- (2017) Jann N Sarkaria et al. NEURO-ONCOLOGY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brain Pericytes As Mediators of Neuroinflammation
- (2017) Justin Rustenhoven et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Biomarkers for Parkinson’s Disease: Recent Advancement
- (2017) Sharvari Lotankar et al. Neuroscience Bulletin
- Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
- (2017) Mikako Ogawa et al. Oncotarget
- Near-infrared photoimmunotherapy: a comparison of light dosing schedules
- (2017) Fusa Ogata et al. Oncotarget
- Correlation of Circulating T Lymphocytes and Intracranial Hypertension in Intracerebral Hemorrhage
- (2017) Wanqiang Su et al. World Neurosurgery
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
- (2017) Matthias Van Woensel et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
- (2016) Jack M. Qian et al. CANCER
- Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
- (2016) Chiara Bardella et al. CANCER CELL
- Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
- (2016) Benjamí Oller-Salvia et al. CHEMICAL SOCIETY REVIEWS
- Cellular immunotherapy for malignant gliomas
- (2016) Yi Lin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Recent advances and future of immunotherapy for glioblastoma
- (2016) Neha Kamran et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Harnessing nanomedicine for therapeutic intervention in glioblastoma
- (2016) Anna Gutkin et al. Expert Opinion on Drug Delivery
- mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
- (2016) Laura Garros-Regulez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme
- (2016) Szu-Ting Chou et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic approaches in Parkinson's disease and related disorders
- (2016) Elvira Valera et al. JOURNAL OF NEUROCHEMISTRY
- How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
- (2016) Laura A. Volpicelli-Daley et al. JOURNAL OF NEUROCHEMISTRY
- From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
- (2016) William A. Banks NATURE REVIEWS DRUG DISCOVERY
- Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo
- (2016) Emese Szabo et al. NEURO-ONCOLOGY
- Review: Parkinson's disease: from synaptic loss to connectome dysfunction
- (2016) Arianna Bellucci et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
- (2016) Hua Jing et al. Theranostics
- Strategies for transporting nanoparticles across the blood–brain barrier
- (2016) Tian-Tian Zhang et al. Biomaterials Science
- Penetrating the Blood–Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles
- (2015) Iqbal Unnisa Ali et al. ACS Nano
- Down syndrome and Alzheimer's disease: Common pathways, common goals
- (2015) Dean Hartley et al. Alzheimers & Dementia
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Synthetic Nanoparticles for Vaccines and Immunotherapy
- (2015) Darrell J. Irvine et al. CHEMICAL REVIEWS
- Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
- (2015) M. Verreault et al. CLINICAL CANCER RESEARCH
- Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
- (2015) Giovanna Lollo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model
- (2015) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- Convection-enhanced delivery to the central nervous system
- (2015) Russell R. Lonser et al. JOURNAL OF NEUROSURGERY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
- (2015) Benjamin Dehay et al. LANCET NEUROLOGY
- EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling
- (2015) Feng Liu et al. MOLECULAR CELL
- Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
- (2015) Markus Mandler et al. Molecular Neurodegeneration
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Blood-brain barrier modeling: challenges and perspectives
- (2015) Tobias Ruck et al. Neural Regeneration Research
- Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
- (2015) Kathryn M. Field et al. NEURO-ONCOLOGY
- Immunotherapeutic Approaches for Alzheimer’s Disease
- (2015) Thomas Wisniewski et al. NEURON
- Organotypic brain slice cultures: A review
- (2015) C. Humpel NEUROSCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug
- (2015) Martyn A. Sharpe et al. EBioMedicine
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Antibodies and protein misfolding: From structural research tools to therapeutic strategies
- (2014) Erwin De Genst et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Galectin-1 and Immune Suppression during Radiotherapy
- (2014) J. W. Welsh et al. CLINICAL CANCER RESEARCH
- Immunotherapy for Brain Cancer: Recent Progress and Future Promise
- (2014) C. M. Jackson et al. CLINICAL CANCER RESEARCH
- Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
- (2014) Allal Boutajangout et al. GERONTOLOGY
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
- (2014) Samir Mitragotri et al. NATURE REVIEWS DRUG DISCOVERY
- Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases
- (2014) He-Jin Lee et al. Nature Reviews Neurology
- Parkinson’s disease: animal models and dopaminergic cell vulnerability
- (2014) Javier Blesa et al. Frontiers in Neuroanatomy
- Active immunotherapy options for Alzheimer’s disease
- (2014) Bengt Winblad et al. Alzheimers Research & Therapy
- The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma
- (2014) Minghui Li et al. Journal for ImmunoTherapy of Cancer
- Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents
- (2013) Houshang Amiri et al. ACS Chemical Neuroscience
- Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- (2013) Ariadna Recasens et al. ANNALS OF NEUROLOGY
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
- (2013) Tina Verschuere et al. JOURNAL OF NEURO-ONCOLOGY
- A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric A , and Frank Neuronal Loss
- (2013) R. M. Cohen et al. JOURNAL OF NEUROSCIENCE
- Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
- (2013) Manfred Westphal et al. LANCET ONCOLOGY
- Physiology of Blood–Brain Interfaces in Relation to Brain Disposition of Small Compounds and Macromolecules
- (2013) N. Strazielle et al. MOLECULAR PHARMACEUTICS
- Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
- (2013) Kaj Blennow et al. NEUROPSYCHOPHARMACOLOGY
- Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
- (2013) Cintia Roodveldt et al. PLoS One
- Multicellular Self-Assembled Spheroidal Model of the Blood Brain Barrier
- (2013) Eduard Urich et al. Scientific Reports
- Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier
- (2012) Silke Krol et al. CHEMICAL REVIEWS
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
- (2012) Jason R. Cannon et al. EXPERIMENTAL NEUROLOGY
- Strategies to minimize CNS toxicity:in vitrohigh-throughput assays and computational modeling
- (2012) Travis T Wager et al. Expert Opinion on Drug Metabolism & Toxicology
- Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
- (2012) Richard A. Morgan et al. HUMAN GENE THERAPY
- Regulatory T cells in the central nervous system
- (2012) Daniel E. Lowther et al. IMMUNOLOGICAL REVIEWS
- The future of CpG immunotherapy in cancer
- (2012) Behnam Badie et al. Immunotherapy
- Antibody-Aided Clearance of Extracellular -Synuclein Prevents Cell-to-Cell Aggregate Transmission
- (2012) E.-J. Bae et al. JOURNAL OF NEUROSCIENCE
- Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
- (2012) L Toussaint et al. Molecular Cancer
- Immunotherapy for Alzheimer disease—the challenge of adverse effects
- (2012) Yu-Hui Liu et al. Nature Reviews Neurology
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- Theranostic Nanomedicine
- (2011) Twan Lammers et al. ACCOUNTS OF CHEMICAL RESEARCH
- Modern methods for delivery of drugs across the blood–brain barrier
- (2011) Yan Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
- (2011) Nathan Herrmann et al. DRUGS
- Photodynamic therapy boosts anti-glioma immunity in mice: A dependence on the activities of T cells and complement C3
- (2011) Fei Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
- (2011) Natalia N. Nalivaeva et al. JOURNAL OF NEUROCHEMISTRY
- Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
- (2011) James Scott Miners et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
- (2011) Makoto Mitsunaga et al. NATURE MEDICINE
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- Nanomedicine
- (2010) Betty Y.S. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticle Delivery Systems in Cancer Vaccines
- (2010) Yogita Krishnamachari et al. PHARMACEUTICAL RESEARCH
- Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
- (2009) Marianela Candolfi et al. CURRENT GENE THERAPY
- Active and Passive Immunotherapy for Neurodegenerative Disorders
- (2008) David L. Brody et al. Annual Review of Neuroscience
- Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
- (2008) Thomas Schneider et al. JOURNAL OF NEUROIMMUNOLOGY
- Cancer Immunotherapy
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synuclein activates microglia in a model of Parkinson's disease
- (2007) Xiaomin Su et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started